文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

血浆血管生成素-2作为脓毒症相关ARDS发展的潜在因果标志物:孟德尔随机化和中介分析的证据

Plasma angiopoietin-2 as a potential causal marker in sepsis-associated ARDS development: evidence from Mendelian randomization and mediation analysis.
PubMed 文献 · Intensive Care Med · 2018-10-21
一句话结论在脓毒症欧洲裔患者中,ANGPT2基因变异rs2442608C与ARDS风险升高相关,血浆ANG2可能介导34%的该遗传风险,提示ANG2可能是ARDS的因果因素。

该研究对703例脓毒症患者进行基因分型,测量ICU入院时血浆血管生成素-2(ANG2),并进行定量性状位点(QTL)分析。在404例欧洲裔受试者中,5个ANGPT2变异与ANG2相关;最显著的cis QTL rs2442608C与较高ARDS风险相关(校正OR 1.38,95%CI 1.01-1.87,p=0.042)。遗传预测的血浆ANG2与ARDS风险相关(校正OR 2.25,95%CI 1.06-4.78,p=0.035),血浆ANG2介导了34%的rs2442608C相关ARDS风险。作者认为血浆ANG2可能是ARDS发展的因果因素,降低血浆ANG2的策略值得测试以预防或治疗脓毒症相关ARDS。

要点

  • 在703例脓毒症患者中,血浆ANG2与ARDS强烈相关(每log OR 1.59,95%CI 1.35-1.88)。
  • 在欧洲裔受试者(n=404)中,ANGPT2变异rs2442608C与较高ARDS风险相关(校正OR 1.38,95%CI 1.01-1.87,p=0.042)。
  • 遗传预测的血浆ANG2与ARDS风险相关(校正OR 2.25,95%CI 1.06-4.78,p=0.035)。
  • 血浆ANG2介导了34%的rs2442608C相关ARDS风险。
  • 作者认为血浆ANG2可能是ARDS发展的因果因素,降低血浆ANG2的策略值得测试以预防或治疗脓毒症相关ARDS。

适用人群与场景

  • 703例脓毒症患者,测量ICU入院时血浆ANG2并进行基因分型;QTL分析在404例欧洲裔受试者中进行,非洲裔受试者中未识别到显著QTL。

研究设计与关键结果

  • 研究类型为遗传因果推断研究,采用孟德尔随机化和中介分析;样本量703例脓毒症患者,其中欧洲裔404例。
  • 血浆ANG2与ARDS强烈相关:OR 1.59(95%CI 1.35-1.88)每log。
  • 在欧洲裔受试者中,5个ANGPT2变异与ANG2相关;最显著的cis QTL rs2442608C系数0.22(95%CI 0.09-0.36,p=0.001)。
  • rs2442608C与较高ARDS风险相关:校正OR 1.38(95%CI 1.01-1.87),p=0.042。
  • 非洲裔受试者中未识别到显著QTL。
  • 遗传预测的血浆ANG2与ARDS风险相关:校正OR 2.25(95%CI 1.06-4.78),p=0.035。
  • 血浆ANG2介导了34%的rs2442608C相关ARDS风险。

证据类型、等级与局限

  • 证据类型为遗传因果推断研究(孟德尔随机化和中介分析),非随机对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为血浆ANG2可能是ARDS发展的因果因素,降低血浆ANG2的策略值得测试以预防或治疗脓毒症相关ARDS。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: A causal biomarker for acute respiratory distress syndrome (ARDS) could fuel precision therapy options. Plasma angiopoietin-2 (ANG2), a vascular permeability marker, is a strong candidate on the basis of experimental and observational evidence. We used genetic causal inference methods-Mendelian randomization and mediation-to infer potential effects of plasma ANG2.

METHODS: We genotyped 703 septic subjects, measured ICU admission plasma ANG2, and performed a quantitative trait loci (QTL) analysis to determine variants in the ANGPT2 gene associated with plasma ANG2 (p < 0.005). We then used linear regression and post-estimation analysis to genetically predict plasma ANG2 and tested genetically predicted ANG2 for ARDS association using logistic regression. We estimated the proportion of the genetic effect explained by plasma ANG2 using mediation analysis.

RESULTS: Plasma ANG2 was strongly associated with ARDS (OR 1.59 (95% CI 1.35, 1.88) per log). Five ANGPT2 variants were associated with ANG2 in European ancestry subjects (n = 404). Rs2442608C, the most extreme cis QTL (coefficient 0.22, 95% CI 0.09-0.36, p = 0.001), was associated with higher ARDS risk: adjusted OR 1.38 (95% CI 1.01, 1.87), p = 0.042. No significant QTL were identified in African ancestry subjects. Genetically predicted plasma ANG2 was associated with ARDS risk: adjusted OR 2.25 (95% CI 1.06-4.78), p = 0.035. Plasma ANG2 mediated 34% of the rs2442608C-related ARDS risk.

CONCLUSIONS: In septic European ancestry subjects, the strongest ANG2-determining ANGPT2 genetic variant is associated with higher ARDS risk. Plasma ANG2 may be a causal factor in ARDS development. Strategies to reduce plasma ANG2 warrant testing to prevent or treat sepsis-associated ARDS.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Reilly JP, Wang F, Jones TK, et al. Plasma angiopoietin-2 as a potential causal marker in sepsis-associated ARDS development: evidence from Mendelian randomization and mediation analysis. Intensive Care Med. 2018. PMID: 30343317. doi:10.1007/s00134-018-5328-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。